We are live on
!
Find out more
HP
Harbourvest Partners Portfolio holdings
AUM
$101M
1-Year Est. Return
38.13%
This Fund
S&P 500
This Quarter
Est. Return
-12.37%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$166M
AUM Growth
-$15.6M
(-8.6%)
Cap. Flow
+$6.24M
Cap. Flow
% of AUM
3.77%
Top 10 Holdings %
Top 10 Hldgs %
98.78%
Holding
18
New
9
Increased
2
Reduced
1
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HAPN
Happen Inc
HAPN
|
+$4.62M |
| 2 |
Box
BOX
|
+$3.94M |
| 3 |
XLRN
Acceleron Pharma
XLRN
|
+$3.36M |
| 4 |
YUMA
Yuma Energy Inc
YUMA
|
+$2.13M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$1.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Range Resources
RRC
|
+$9.18M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
+$2.36M |
| 3 |
SCTY
SolarCity Corporation
SCTY
|
+$565K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 82.14% |
| 2 | Financials | 6.03% |
| 3 | Healthcare | 5.41% |
| 4 | Technology | 2.31% |
| 5 | Energy | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Wayfair
W
$12.5B
| $135M | 81.73% |
3,860,511
+16,842
| +0.4% | +$606K |
|
|
HAPN
2
Happen Inc
HAPN
$2.19B
| $9.98M | 6.03% |
380,041
+168,174
| +79% | +$4.62M |
|
|
FNJN
3
DELISTED
Finjan Holdings, Inc.
FNJN
| $4.88M | 2.94% |
4,303,435
| – | – |
|
|
4
Box
BOX
$4.36B
| $3.69M | 2.23% |
+266,399
| New | +$3.94M |
|
|
XLRN
5
DELISTED
Acceleron Pharma
XLRN
| $2.7M | 1.63% |
+105,964
| New | +$3.36M |
|
|
YUMA
6
DELISTED
Yuma Energy Inc
YUMA
| $1.92M | 1.16% |
+37,606
| New | +$2.13M |
|
|
TRVN
7
DELISTED
Trevena, Inc.
TRVN
| $1.83M | 1.11% |
499
| – | – |
|
|
GBT
8
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.36M | 0.82% |
+93,960
| New | +$1.65M |
|
|
SAGE
9
DELISTED
Sage Therapeutics
SAGE
| $1.18M | 0.71% |
23,168
-50,000
| -68% | -$2.36M |
|
10
Tesla
TSLA
$1.21T
| $678K | 0.41% |
+47,625
| New | +$626K |
|
11
Editas Medicine
EDIT
$402M
| $590K | 0.36% |
36,362
| – | – |
|
|
MYOK
12
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $572K | 0.35% |
+44,145
| New | +$680K |
|
13
Voyager Therapeutics
VYGR
$184M
| $463K | 0.28% |
+36,362
| New | +$467K |
|
14
Atara Biotherapeutics
ATRA
$70.4M
| $150K | 0.09% |
422
| – | – |
|
|
SSNI
15
DELISTED
Silver Spring Networks, Inc.
SSNI
| $137K | 0.08% |
+10,320
| New | +$143K |
|
16
CytomX Therapeutics
CTMX
$701M
| $110K | 0.07% |
+10,000
| New | +$121K |
|
|
17
Range Resources
RRC
$8.94B
| – | – |
-236,920
| Closed | -$9.18M |
|
|
SCTY
18
DELISTED
SolarCity Corporation
SCTY
| – | – |
-28,870
| Closed | -$565K |
|
Similar funds
VCM
TCI
RPC
XC
AWA
HWM
CG
ROP
Harbourvest Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Harbourvest Partners held 18 positions worth $166M, down 8.6% from $181M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Harbourvest Partners deployed $6.24M of net new capital in Q4 2016, opening 9 new positions and adding to 2 existing holdings. Its largest new stake was Box: 266,399 shares worth $3.69M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 82% of assets, down from 84% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Sage Therapeutics, an estimated $2.36M trimmed.
- Harbourvest Partners's largest Q4 2016 buy was Box: 266,399 shares worth $3.69M.
- Harbourvest Partners added most to Happen Inc in Q4 2016, an estimated $4.62M increase.
- Harbourvest Partners's biggest Q4 2016 reduction was Sage Therapeutics, cutting an estimated $2.36M.
- Harbourvest Partners fully exited Range Resources in Q4 2016, selling an estimated $9.18M.
- Harbourvest Partners's ten largest holdings make up 99% of its $166M portfolio in Q4 2016.
- Harbourvest Partners opened 9 new positions and closed 2 in Q4 2016.
- Harbourvest Partners's portfolio value fell 8.6% quarter-over-quarter to $166M.
Based on Harbourvest Partners's 13F filing for Q4 2016, filed 14 Feb 2017.